Craft

Nemaura Medical

Stock Price

$0

2024-10-29

Market Capitalization

$8.1 K

2024-10-29

Revenue

$77 K

FY, 2023

Nemaura Medical Summary

Company Summary

Overview
Nemaura Medical is a medical technology company. It develops a micro-system-based drug delivery platform such as sugarBEAT and BEAT diabetes non-invasive continuous glucose monitoring systems for Type 1 or Type 2 diabetes. The company’s platforms allow the monitoring of multiple chemicals in the blood without using needles.
Type
Public
Status
Active
Founded
2011
HQ
Loughborough, GB | view all locations
Website
https://nemauramedical.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Faz Chowdhury, Chief Executive Officer, Director

    • Justin McLarney, Chief Finance Officer

    • Karrar Khan, Director of Product Development

      • Fred Schaebsdau

        Fred Schaebsdau, Managing Director

      LocationsView all

      5 locations detected

      • Loughborough, England HQ

        United Kingdom

        Oakwood Dr

      • Denver, CO

        United States

        4600 S Ulster St #900

      • New York, NY

        United States

        135 E 57th St 18th floor

      • Reno, NV

        United States

        50 W. Liberty, 50 W Liberty St #880

      • West Palm Beach, FL

        United States

        625 N Flagler Dr #600

      Nemaura Medical Financials

      Summary Financials

      Net income (Q3, 2024)
      ($2.2M)
      Cash (Q3, 2024)
      $137.4K
      EBIT (Q3, 2024)
      ($1.5M)
      Enterprise value
      $19.5M

      Footer menu